Fractyl Health, Inc. (GUTS) Stock
Fractyl Health stock price chart
GUTS stock quote & key statistics
Fractyl Health annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$141.0M | -$2.29 |
| FY2024 | $93,000 | -$68.7M | -$0.96 |
| FY2023 | $120,000 | -$77.1M | — |
| FY2022 | $0 | -$46.5M | — |
| FY2021 | $0 | -$38.7M | — |
Fiscal year ending September 30. Source: company filings via EODHD.
About Fractyl Health, Inc.
Fractyl Health, Inc., a leader in metabolic therapeutics, focuses on pioneering treatments for type 2 diabetes (T2D) and obesity. At the forefront of its innovative approach is the Revita DMR System (Revita), an outpatient procedural therapy designed to address duodenal dysfunction a condition linked to high fat and high sugar diets that can trigger T2D and obesity in individuals.
In addition to Revita, Fractyl Health is advancing Rejuva, a groundbreaking platform based on adeno-associated virus delivery. This novel pancreatic gene therapy aims to achieve long-term remission of T2D and obesity by fundamentally altering metabolic hormone function within the pancreatic islet cells of patients.
Formerly known as Fractyl Laboratories Inc., the company underwent a name change to Fractyl Health, Inc. in June 2021. Founded in 2010 and headquartered in Burlington, Massachusetts, Fractyl Health continues to drive forward with its mission to revolutionize the treatment landscape for metabolic diseases through innovative therapeutic solutions.
Fractyl Health stock FAQ
What is the Fractyl Health stock ticker symbol?
Fractyl Health, Inc. trades on the NASDAQ under the ticker symbol GUTS.
What sector and industry is Fractyl Health in?
Fractyl Health, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Fractyl Health have?
Fractyl Health, Inc. has about 100 full-time employees.
What were Fractyl Health's revenue and earnings last fiscal year?
Fractyl Health reported revenue of $0 and net income of -$141.0M in fiscal 2025, with earnings per share of -$2.29. Revenue declined 100.0% from the prior year.
When did Fractyl Health go public?
Fractyl Health stock began trading on February 2, 2024.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex